Janssen’s ulcerative colitis medicine not recommended by NICE for use in adults
January 21, 2020Manufacturing and Production IBS, Irrated Bowels, NHS, NICE, bowel, ulcerative colitis
NICE has published draft guidance which does not recommend Stelara (ustekinumab) for treating moderately to severely active ulcerative colitis in …
Jazz Pharma’s Sunosi becomes first EU-approved drug of its kind in narcolepsy and sleep apnoea
January 21, 2020Manufacturing and Production, Sales and Marketing jazz pharmaceuticals, narcolepsy, pharma
Jazz Pharmaceuticals has secured approval from the European Commission for Sunosi (solriamfetol), it has emerged, as a therapy to improve …
Cardiff University team discovers new method of killing cancers
January 21, 2020Manufacturing and Production Cancer, Cancer cures, Cancerous, Cardiff University, T cell, cells, immune system, immunity, t-cell
A team at Cardiff University have discovered a new part of the human immune system that could be harnessed to …
Novartis’ Mayzent granted license by the European Medicines Agency
January 21, 2020Manufacturing and Production CNS, European Medicines Agency, NHS, NICE, Novartis
The European Medicines Agency (EMA) has granted a licence for the use of Mayzent (siponimod) in the treatment of certain …
FDA warning letters to Indian pharmaceutical companies double in 2019
January 20, 2020Sales and Marketing Indian Pharma, Indian Pharmaceuticals
Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019 compared …
Lynparza secures accelerated FDA review for metastatic castration-resistant prostate cancer
January 20, 2020Sales and Marketing Cancer, FDA, lynparza, pharma
Following the recommendation of the tablet formulation of the drug for use on the NHS in England and Wales, news …
Collaborating to realise the potential of precision medicine
January 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Precision Medicine, feature, pharma
Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the …
US judge slashes Johnson & Johnson damages in Risperdal case
January 20, 2020Sales and Marketing Big Pharma, Johnson & Johnson, Johnson & Johnson talc powder
A judge in Philadelphia has reduced the amount of damages Johnson & Johnson was ordered to pay by a jury …
NICE turns down Bayer’s tumour-agnostic therapy Vitrakvi over evidence concerns
January 20, 2020Sales and Marketing Bayer, Cancer, NICE, Vitravki
UK drug watchdog NICE has turned down Bayer’s Vitrakvi (larotrectinib) as a tumour-agnostic treatment solution on the NHS after it …
WHO officials say Wuhan viral pneumonia outbreak can be passed from person to person
January 20, 2020Sales and Marketing China, Sars, Viral pneumonia, WHO, World Health Organisation, Wuhan Outbreak
The viral pneumonia outbreak that began in Wuhan China can spread between person to person, according to health experts at …
Ipsen appoints new Exec VP and Chief Medical Officer
January 17, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma
Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs …
Top Ten most popular articles on Pharmafile.com this week
January 17, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, European Commission, FDA, Pakistan, Sanofi, Teva
Pakistan is cracking down on corruption and has registered cases against 200 pharmaceutical companies, while in the US the FDA …
Japan welcomes approval of ViiV’s Dovato for HIV-1
January 17, 2020Medical Communications, Sales and Marketing Dovato, Japan, ViiV Healthcare, pharma
Japan’s Ministry of Health, Labour and Welfare (MHLW) has awarded marketing approval to ViiV Healthcare, a subsidiary of GSK, for …
UK trial aims to find treatments that can slow or reverse motor neurone disease
January 17, 2020Medical Communications MND, Motor Neurone, clinical trial, motor neurone disease, trial
A UK wide trial called MND-SMART has invited hundreds of people with motor neurone disease (MND) to participate. It will …
China’s viral pneumonia spreads to Japan
January 17, 2020Medical Communications China, Japan, Sars, Viral pneumonia, Wuhan, epidemic, pandemic, pneumonia
A recent strain of viral pneumonia has spread from China to Japan, prompting fears of a global pandemic. A man …
Novo’s semaglutide injection and tablets get expanded FDA approval for type 2 diabetes with established CVD
January 17, 2020Medical Communications, Sales and Marketing FDA, Novo Nordisk, Ozempic, cardiovascular disease, diabetes, pharma
Novo Nordisk has seen label expansions approved from the FDA for both its glucagon-like peptide-1 (GLP-1) analogue injection Ozempic (once-weekly …
Lynparza tablets approved for NHS use in platinum-sensitive, BRCA-mutated ovarian, fallopian tube or peritoneal cancer
January 16, 2020Sales and Marketing AstraZeneca, MSD, NHS, NICE, UK, lynparza
It has been announced that tablet form of Lynparza (olaparib), the PARP inhibitor developed by AstraZeneca and MSD, has secured …
US-China trade deal sees changes on drug patents
January 16, 2020Business Services China, Chinese Drug Patents, Trade Deal, US Drug Patents, US-China Trade Deal
The US and China signed the first part of a broader trade pact that included setting up a system to …
AbbVie’s Skyrizi outpaces Novartis’ Cosentyx in plaque psoriasis skin clearance
January 16, 2020Research and Development AbbVie, Cosentyx, Novartis, Skyrizi, pharma, psoriasis
AbbVie has made it known that Skyrizi (risankizumab) outpaced Novartis’ Cosentyx (secukinumab) at Phase 3 in the treatment of plaque …
HIV infections fall by 73% in bi and gay British men
January 16, 2020Business Services AIDS, AIDS Epidemic, HIV, NHS, NHS England, PrEP, nhs scotland
Public Health England has released figures that show that HIV rates in bi and gay men have fallen by 73% …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
